Trial Profile
Prospective study on clinical efficacy of Zofigo on castration resistant prostate cancer with bone metastasis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2017
Price :
$35
*
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 27 Sep 2016 New trial record